Cited 0 times in 
Cited 3 times in 
The Impact of the Novel Sodium-Dependent Glucose Cotransporter 2 Inhibitor, Enavogliflozin, on Cardiac Reverse Remodeling in Heart Failure Patients With Type 2 Diabetes Mellitus: A Case Series
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.